Opinion
Video
Oral JAK Inhibitors in Atopic Dermatitis
Author(s):
Ruth Ann Vleugels, MD, MPH, MBA, provides an overview of oral JAK inhibitors approved for the treatment of atopic dermatitis and describes what makes them an attractive therapeutic option.
Video content above is prompted by the following questions:
- Please review the oral JAK inhibitors that have been approved for atopic dermatitis (AD).
- Which patients are they approved for?
- What makes JAK inhibitors an attractive option for AD treatment?
- How are oral JAK inhibitors utilized in other diseases?
Related Videos
Related Content
